Citrini Bets on Life Sciences Stocks After Claude AI Drug Study

bloomberg

·

Original Report

↗ bloomberg

Life sciences companies stand to gain from a surge in artificial intelligence fueled drug discovery, says Citrini Research after testing Anthropic PBC’s Claude Science.